Naval Medical Center Camp Lejeune
1 trialPhase 31 person
VA Office of Research and Development
1 trialPhase 2/3519 people
The University of Texas Health Science Center at San Antonio
1 trialPhase 2/324 people
University Health Network, Toronto
1 trialPhase 276 people
Masonic Cancer Center, University of Minnesota
1 trialPhase 244 people
1 trialPhase 244 people
1 trialPhase 212 people
1 trialPhase 1/2500 people
Japan Society for the Promotion of ScienceJP¥21.3mSlovenian Research and Innovation Agency
Japan Society for the Promotion of ScienceUniversity of MiyazakiJP¥4.6m2026–2029
Regenerative medicine using iPS cells with suicide gene for Parkinson's disease
Japan Society for the Promotion of ScienceKeio UniversityJP¥4.7m2022–2025
Regenerative medicine using iPS cells with suicide gene for cerebral infarction
Japan Society for the Promotion of ScienceKeio UniversityJP¥4.3m2020–2023
Telomere length and mitochondrial DNA copy number in blood and brain of suicide completers
Japan Society for the Promotion of ScienceKobe UniversityJP¥3.9m2016–2019
Japan Society for the Promotion of ScienceJuntendo UniversityJP¥3.9m2016–2020
The disease-free share declined by nearly 1% annually, while most groups saw five-year death risks stall or rise after the mid-2000s.The disease-free share declined by nearly 1% annually, while most groups saw five-year death risks stall or rise after the mid-2000s.
In 4.6 million Korean adults, advanced CKM stages 3 and 4 were associated with adjusted hazard ratios for suicidal death of 1.328 and 1.319.In 4.6 million Korean adults, advanced CKM stages 3 and 4 were associated with adjusted hazard ratios for suicidal death of 1.328 and 1.319.
Total deaths rose from 13,567 in 2000 to 27,792 in 2023, while regional rates shifted slightly from 14.46 to 14.95 per 100,000.Total deaths rose from 13,567 in 2000 to 27,792 in 2023, while regional rates shifted slightly from 14.46 to 14.95 per 100,000.